WCG
HCAT icon

Weaver Consulting Group’s Health Catalyst HCAT Stock Holding History

Weaver Consulting Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$18K – 449
2020
Q3 		$18K Hold
500
– – 0.01% 421
2020
Q2 		$15K Buy
+500
New +$13.8K 0.01% 440

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Weaver Consulting Group's HCAT Position: Q4 2020 in Review

Weaver Consulting Group sold out of Health Catalyst (HCAT) in Q4 2020, closing a stake of 500 shares — an estimated $18K sold.

Weaver Consulting Group first reported a position in HCAT in Q2 2020 and held it in 2 quarters. The position peaked at $18K in Q3 2020. 168 funds tracked by Wall St. Rank hold HCAT as of Q4 2020.

  • Weaver Consulting Group reported no remaining Health Catalyst position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 500 Health Catalyst shares in Q4 2020, an estimated $18K.
  • Weaver Consulting Group first reported a position in Health Catalyst in Q2 2020 and held it in 2 quarters.
  • Weaver Consulting Group's Health Catalyst position peaked at $18K in Q3 2020.
  • 168 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.